HOME >> BIOLOGY >> NEWS
Improving crops without genetic modification natural variation holds the key

Traditional plant breeders improve the quality and yield of crops by crossing plants with desired traits to create a new, hopefully improved, hybrid strain. But traditional breeding is limited by the available gene pool of a cultivated plant species and eventually hits a wall--reshuffling the same genetic variation can boost yield only so much. With the advent of biotechnology, plant scientists were buoyed by the prospect of improving plants through genetic modification. But aside from a few successes with introducing single-gene herbicide- and pest-resistant traits, most plant traits have proved too complex to repay the incorporation of a single transgene--that is, a gene taken from a different species--with the hoped-for response. Biotech-based investigations and applications in plant science have also been hampered by consumer reaction against genetically modified organisms.

Faced with these limitations, Amit Gur and Dani Zamir of The Hebrew University of Jerusalem tried another approach--a back-to-nature approach. "Natural biodiversity is an unexploited sustainable resource that can enrich the genetic basis of cultivated plants," they explain in the report.

First Gur and Zamir identified genomic regions in wild tomato species that affect yield, by creating a population of hybrid crosses of a wild tomato species and a cultivated tomato species; each line had a single genomic region from the wild tomato inserted into the cultivated plant. They then combined three independent yield enhancing genomic regions from the wild species into the new plant line. Plants were grown over three seasons, during which they were exposed to different environments, including drought. By combining traditional breeding techniques with genetic marker analysis, the authors identified a number of wild tomato genomic regions that dramatically increased yield.

Their results demonstrate that an approach based on biodiversity--which takes advantage of the rich genet
'"/>

Contact: Paul Ocampo
pocampo@plos.org
1-415-624-1224
Public Library of Science
23-Aug-2004


Page: 1 2

Related biology news :

1. Improving the bodys homeland security against TB
2. Improving fertilizer efficiency
3. Improving bone implant technology
4. Improving water use in growing corn possible, study shows
5. Improving preventative care for coronary bypass patients
6. New England Water Is Improving But Problems Remain, Says New USGS Report
7. Improving Salmon Management
8. NASA Exhibit, Experts To Be In Baltimore Focusing On Space Research Improving Earth-Based Health Care
9. Pennsylvanias R&D Climate Improving
10. Domesticated tree crops may be the future of forestry
11. Disease threatens cucumbers, pumpkins, and other vine crops

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2019)... ... , ... ActX has launched a medical genetic interpretation ... can get access to professionally reviewed genetic screening similar to what a physician ... + Ancestry customers., With the ActX + 23andMe service, both 23andMe customers and ...
(Date:6/24/2019)... ... , ... According to the World Health Organization , over a million ... gonorrhea, trichomoniasis (or "trich") and syphilis. And that’s not counting HIV. , In ... for the largest number of HIV diagnoses (9,807), followed by Hispanic/Latino men (7,436) and ...
(Date:6/20/2019)... ... June 19, 2019 , ... ... Infectious Diseases Society of America Foundation, and the possibly millions of dollars of ... infectious agents in AD, are a “welcome affirmation” of the need to investigate ...
Breaking Biology News(10 mins):
(Date:6/26/2019)... ... ... Alice Branton today released research results from preclinical trials on the beneficial ... prove to be beneficial for treating Hypomagnesemia. , The preclinical trial shows:, ... , Over 142% increase in particle size , Over 3% ...
(Date:6/18/2019)... YORK and SOMERSET, N.J. (PRWEB) , ... June ... ... Catalent Biologics, today announced that they have entered into an agreement for production ... product candidates, IC-100 for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) ...
(Date:6/18/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell ... of a person’s own adipose-derived stem cells to treat their osteoarthritis. The first clinical ... IND is the first of several planned clinical trials which will enable qualified PSC-enrolled ...
(Date:6/12/2019)... (PRWEB) , ... June 12, 2019 , ... ... built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food ... Zillion has been signed. The agreement will grant exclusive rights for Zillion to ...
Breaking Biology Technology:
Cached News: